Concepedia

Clinico-radiologic features and therapeutic strategies in tumefactive demyelination: a retrospective analysis of 50 consecutive cases

Aigli G. Vakrakou, Dimitrios Tzanetakos, Maria‐Eleftheria Evangelopoulos, Theodore Argyrakos, John S. Tzartos, Maria Anagnostouli, Georgios Koutsis, Georgios Velonakis, Panagiotis Toulas, Elias Gialafos,

Therapeutic Advances in Neurological Disorders · 2021 · 17 citations · 22 references

DOIFull text

Open access

Abstract

Tumefactive central nervous system demyelination is an heterogenous disease; its stratification into distinct groups according to different phenotypes can establish more efficient treatment strategies, thus improving clinical outcomes in the future.

References

22

2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

Martin Aringer, Karen H. Costenbader, David Daikh et al. · Arthritis & Rheumatology · 2019 · 2.3K citations · Full text

Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis

Claudia F. Lucchinetti, Ralitza H. Gavrilova, Imke Metz et al. · Brain · 2008 · 478 citations · Full text

Failure of Natalizumab to Prevent Relapses in Neuromyelitis Optica

Ingo Kleiter · Archives of Neurology · 2012 · 293 citations · Full text

Immune Reconstitution Inflammatory Syndrome in Patients With Multiple Sclerosis Following Cessation of Natalizumab Therapy

Augusto Miravalle, Rikke Beck Jensen, R. Philip Kinkel · Archives of Neurology · 2010 · 174 citations

Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study

Bradley J. Petek, Murat Terzi, Sebahattin Saip et al. · Multiple Sclerosis Journal · 2012 · 146 citations